Frank E. Jaumot - 23 Apr 2026 Form 4 Insider Report for Nutex Health Inc. (NUTX)

Reporting relationship: Director
Issuer ticker: NUTX
Reported as of: 23 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Apr 2026, 14:27:51 UTC
Prior SEC filing: 23 Mar 2026
Next SEC filing: 03 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Frank E. Jaumot

Key filing fact

Frank E. Jaumot filed Form 4 for Nutex Health Inc. (NUTX) on 24 Apr 2026.

Key facts

This page summarizes Frank E. Jaumot's Form 4 filing for Nutex Health Inc. (NUTX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 24 Apr 2026, 14:27.

Change

Previous filing in this sequence was filed on 23 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001303609 Primary reporting owner

Jaumot Frank E

Relationship: Director
Address: 1776 YORKTOWN STREET SUITE 700, C/O NUTEX HEALTH INC., HOUSTON
Signature: /s/ Frank E. Jaumot
Signature date: 24 Apr 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NUTX transaction Derivative

Restricted Stock Units (RSUs)

Award

Transaction value
Shares: +823
Change %: +136%
Price: $0.000000^*
Shares after: 1,426
Date: 23 Apr 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 823
Exercise price: $0.000000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each RSU represents a contingence right to receive one share of the issuer's common stock, $0.001 par value, upon vesting.

Footnote F2

On April 23, 2026, the Reporting Person was granted 823 RSUs, which vest 100% on April 23, 2027. If the Reporting Person leaves service with Company without cause, during the vesting period, the RSUs shall vest on a pro-rata basis for the actual time in service for the Company.